LARGO, Fla., Sept. 18, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today it received a Nasdaq Staff Deficiency Letter on September 15th, 2009 indicating that the Company does not comply with the Minimum Bid Price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2).
